OsimertinibDevelopment of resistance in non-small cell lung cancer: 3 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1880卷 / 1期

关键词：

D O I：

10.1007/s40278-021-05145-1

中图分类号：

学科分类号：

摘要：

引用

页码：311 / 311

共 50 条

[31] Afatinib/erlotinib/gefitinibDevelopment of resistance to tyrosine kinase inhibitors in non-small cell lung cancer: 123 case reports
Reactions Weekly, 2021, 1847 (1) : 27 - 27
[32] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
Bar, Jair
Ofek, Efrat
Barshack, Iris
Gottfried, Teodor
Zadok, Oranit
Kamer, Iris
Urban, Damien
Perelman, Marina
Onn, Amir
LUNG CANCER, 2019, 138 : 109 - 115
[33] Mechanisms of resistance to pemetrexed in non-small cell lung cancer
Liang, Jiaqi
Lu, Tao
Chen, Zhencong
Zhan, Cheng
Wang, Qun
TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1107 - 1118
[34] Mechanisms of resistance to chemotherapy in non-small cell lung cancer
Min, Hye-Young
Lee, Ho-Young
ARCHIVES OF PHARMACAL RESEARCH, 2021, 44 (02) : 146 - 164
[35] Mechanisms of resistance to chemotherapy in non-small cell lung cancer
Hye-Young Min
Ho-Young Lee
Archives of Pharmacal Research, 2021, 44 : 146 - 164
[36] CrizotinibDevelopment of resistance during treatment for non-small cell lung cancer: case report
Reactions Weekly, 2017, 1666 (1) : 91 - 91
[37] Gefitinib/osimertinibAcquired resistance in advanced non-small cell lung cancer: case report
Reactions Weekly, 2021, 1863 (1) : 165 - 165
[38] Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1705 (1) : 15 - 15
[39] GefitinibDevelopment of drug resistance in non-small cell lung cancer adenocarcinoma: case report
Reactions Weekly, 2017, 1668 (1) : 192 - 192
[40] Erlotinib/osimertinibDevelopment of drug resistance in lung adenocarcinoma: 2 case reports
Reactions Weekly, 2017, 1668 (1) : 174 - 174

← 1 2 3 4 5 →